These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Protection of Mcc950 against high-glucose-induced human retinal endothelial cell dysfunction. Zhang Y, Lv X, Hu Z, Ye X, Zheng X, Ding Y, Xie P, Liu Q. Cell Death Dis; 2017 Jul 20; 8(7):e2941. PubMed ID: 28726778 [Abstract] [Full Text] [Related]
25. Pharmacological inhibition of the NLRP3 inflammasome as a potential target for cancer-induced bone pain. Chen SP, Zhou YQ, Wang XM, Sun J, Cao F, HaiSam S, Ye DW, Tian YK. Pharmacol Res; 2019 Sep 20; 147():104339. PubMed ID: 31276771 [Abstract] [Full Text] [Related]
26. MCC950 in the treatment of NLRP3-mediated inflammatory diseases: Latest evidence and therapeutic outcomes. Bakhshi S, Shamsi S. Int Immunopharmacol; 2022 May 20; 106():108595. PubMed ID: 35124417 [Abstract] [Full Text] [Related]
27. MCC950 Inhibits NLRP3 Inflammasome and Alleviates Axonal Injures in Early Stages of Diffuse Axonal Injury in Rats. Zhao J, Guo X, Wang B, Yang Z, Huang T, Guo D, Zhang M, Song J. Neurochem Res; 2020 Sep 20; 45(9):2020-2031. PubMed ID: 32474832 [Abstract] [Full Text] [Related]
32. NLRP3 regulates alveolar bone loss in ligature-induced periodontitis by promoting osteoclastic differentiation. Chen Y, Yang Q, Lv C, Chen Y, Zhao W, Li W, Chen H, Wang H, Sun W, Yuan H. Cell Prolif; 2021 Feb 20; 54(2):e12973. PubMed ID: 33382502 [Abstract] [Full Text] [Related]
33. Role of the NLRP3 inflammasome in a model of acute burn-induced pain. Deuis JR, Yin K, Cooper MA, Schroder K, Vetter I. Burns; 2017 Mar 20; 43(2):304-309. PubMed ID: 28040362 [Abstract] [Full Text] [Related]
34. The covalent NLRP3-inflammasome inhibitor Oridonin relieves myocardial infarction induced myocardial fibrosis and cardiac remodeling in mice. Gao RF, Li X, Xiang HY, Yang H, Lv CY, Sun XL, Chen HZ, Gao Y, Yang JS, Luo W, Yang YQ, Tang YH. Int Immunopharmacol; 2021 Jan 20; 90():107133. PubMed ID: 33168408 [Abstract] [Full Text] [Related]
35. NLRP3 Inflammasome and Mineralocorticoid Receptors Are Associated with Vascular Dysfunction in Type 2 Diabetes Mellitus. Ferreira NS, Bruder-Nascimento T, Pereira CA, Zanotto CZ, Prado DS, Silva JF, Rassi DM, Foss-Freitas MC, Alves-Filho JC, Carlos D, Tostes RC. Cells; 2019 Dec 08; 8(12):. PubMed ID: 31817997 [Abstract] [Full Text] [Related]
36. A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases. Coll RC, Robertson AA, Chae JJ, Higgins SC, Muñoz-Planillo R, Inserra MC, Vetter I, Dungan LS, Monks BG, Stutz A, Croker DE, Butler MS, Haneklaus M, Sutton CE, Núñez G, Latz E, Kastner DL, Mills KH, Masters SL, Schroder K, Cooper MA, O'Neill LA. Nat Med; 2015 Mar 08; 21(3):248-55. PubMed ID: 25686105 [Abstract] [Full Text] [Related]
37. Microglial NLRP3 inflammasome activation mediates IL-1β release and contributes to central sensitization in a recurrent nitroglycerin-induced migraine model. He W, Long T, Pan Q, Zhang S, Zhang Y, Zhang D, Qin G, Chen L, Zhou J. J Neuroinflammation; 2019 Apr 10; 16(1):78. PubMed ID: 30971286 [Abstract] [Full Text] [Related]
38. Inhibition of integrin α5β1 ameliorates VEGF-induced retinal neovascularization and leakage by suppressing NLRP3 inflammasome signaling in a mouse model. Sui A, Zhong Y, Demetriades AM, Lu Q, Cai Y, Gao Y, Zhu Y, Shen X, Xie B. Graefes Arch Clin Exp Ophthalmol; 2018 May 10; 256(5):951-961. PubMed ID: 29502235 [Abstract] [Full Text] [Related]
39. Evidence against a role for NLRP3-driven islet inflammation in db/db mice. Kammoun HL, Allen TL, Henstridge DC, Barre S, Coll RC, Lancaster GI, Cron L, Reibe S, Chan JY, Bensellam M, Laybutt DR, Butler MS, Robertson AAB, O'Neill LA, Cooper MA, Febbraio MA. Mol Metab; 2018 Apr 10; 10():66-73. PubMed ID: 29478918 [Abstract] [Full Text] [Related]
40. Role of the Nucleotide-Binding Domain-Like Receptor Protein 3 Inflammasome in the Endothelial Dysfunction of Early Sepsis. Luo M, Meng J, Yan J, Shang F, Zhang T, Lv D, Li C, Yang X, Luo S. Inflammation; 2020 Aug 10; 43(4):1561-1571. PubMed ID: 32239396 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]